Table 1.
Demographic characteristics and laboratory results of the groups.
| Patients with attack (n =34) | Patients attack-free (n =34) | Control group (n =20) | pa | pb | pc | |
|---|---|---|---|---|---|---|
| Age (years) | 22 (20–37) | 21 (18–31) | 20 (20–29) | 0.245 | 0.581 | 0.112 |
| BMI (kg/m2) | 23.1 (17.8–29.4) | 23.9 (19.3–27.8) | 23.5 (20.9–28.1) | 0.764 | 1 | 0.795 |
| WBC (x103/μl ) | 10.3 (5.3–14.6) | 7.0 (5.1–10.3) | 5.8 (4.8–10) | <0.001 * | 0.061 | <0.001 * |
| Fibrinogen (mg/dl) | 563 (421–898) | 334 (5–631) | 258 (210–417) | <0.001 * | 0.003 * | <0.001 * |
| ESR (mm/h) | 46 (2–101) | 11 (2–78) | 6 (2–24) | <0.001 * | 0.02 * | <0.001 * |
| CRP (mg/l) | 96 (22–204) | 11 (2–72) | 3 (1–12) | <0.001 * | <0.001 * | <0.001 * |
| Resistin (ng/ml) | 30.9 (9–149.1) | 23.3 (8.7–144.7) | 9.3 (3.5–22.1) | 0.122 | <0.001 * | <0.001 * |
| Calprotectin (ng/ml) | 940.5 (633.2–1345.3) | 866.4 (173.1–1099.1) | 588.1 (161.7–1166.5) | 0.004 * | 0.007 * | <0.001 * |
| Disease duration (year) | 14.5 (2–23) | 15 (2–25) |
BMI: body mass index; WBC: white blood cells; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein.
*
p <0.05 was considered statistically significant.
a
Comparison of attack and attack-free FMF patients
b
Comparison of attack and control groups
c
Comparison of attack-free FMF patients and control group